Skip to main content
Glama

Mockdata

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, destructiveHint=false. The description adds substantial behavioral context beyond these: it details the fan-out across multiple sources (SEC, XBRL, USPTO, etc.), mentions the USPTO PatentsView API sunset in May 2025 and that it 'soft-fails until reactivated', explains that empty sections like fda_products are expected for companies without biologics, and clarifies that sources_used/sources_failed indicate real no-data versus bugs. It also explains name resolution behavior and private-company handling. This is rich, non-contradictory context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but every sentence carries operational information. It front-loads usage examples, then details the return structure and source-specific behaviors. There is no fluff or repetition; each clause adds a useful fact. While it could be trimmed slightly (e.g., the parenthetical on FDA products), overall it is efficient for the complexity of the tool. A 4 reflects that it is appropriately detailed without being bloated.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given that the tool has no output schema, the description carries the responsibility of explaining return values, which it does exhaustively: it lists each returned field (cik, company_name, recent_filings with URIs, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI) and explains sources_used/sources_failed. It also covers error semantics (private company resolution) and soft-fail behavior. The only minor omission is rate limits or authentication needs, but these are likely covered by annotations (readOnlyHint). For a multi-source aggregation tool, this description is exceptionally complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so both parameters (type and value) are already documented. The description adds meaningful semantics beyond the schema: it states that 'company' and 'ticker' are interchangeable and both accept ticker, CIK, or name, and that 'person/place coming soon'. It also gives concrete example values for each input form. This goes beyond the schema's terse descriptions, justifying a 4 rather than the baseline 3.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete query examples ('Tell me about X', 'research Acme') immediately establishing the tool's purpose: a full cross-source profile of a US public company in one call. It specifies the verb ('profile'), the resource ('US public company'), and the scope ('full cross-source'). It differentiates from alternatives by stating it should be preferred over chaining single-pack SEC/XBRL/news lookups, though it does not name specific siblings like compare_entities or deep_research, which are distinct enough that an agent would still recognize the intent.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit usage guidance: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also explains when a private company is encountered (returns resolved:false with an explicit notes line), and that empty sections are expected for certain industries. It does not explicitly exclude tools like compare_entities or deep_research, but it gives clear context for when to choose this tool. A 4 is warranted because it lacks explicit 'when not to use' exclusions for overlapping siblings.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Mockdata toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have distinct purposes, but there is overlap within the ask_pipeworx family (beta, grounded) and Polymarket tools (arbitrage, edges, fill_risk), which could cause confusion. Detailed descriptions mitigate this, but the boundaries are not always clear.

Naming Consistency3/5

Tool names use snake_case but lack a consistent verb_noun pattern. Some are imperative (discover_tools), others are descriptive (ask_pipeworx, bet_research), and some are noun phrases (entity_profile, recent_alerts). This inconsistency makes it harder to predict tool names.

Tool Count3/5

33 tools is on the higher side for a single server, but the broad scope (company data, prediction markets, memory, etc.) partially justifies the count. However, many tools are variations of core functionality, suggesting possible consolidation.

Completeness4/5

The tool set covers a wide range of data sources and tasks, including company profiles, comparisons, economic data, and prediction markets. The universal ask_pipeworx router fills most gaps, though some niche data sources might not be directly accessible.

Resources